Phase I Study of the Anti-MUC-l Antibody, huHMFG1 (AS1402), in Patients with Advanced Breast Cancer

MLA

Mark Pegram, and Nigel Courtenay-Luck. “Phase I Study of the Anti-MUC-l Antibody, HuHMFG1 (AS1402), in Patients with Advanced Breast Cancer.” Clinical Immunology, vol. 123, Jan. 2007, pp. S110–11. EBSCOhost, https://doi.org/10.1016/j.clim.2007.03.494.

APA

Mark Pegram, & Nigel Courtenay-Luck. (2007). Phase I Study of the Anti-MUC-l Antibody, huHMFG1 (AS1402), in Patients with Advanced Breast Cancer. Clinical Immunology, 123, S110–S111. https://doi.org/10.1016/j.clim.2007.03.494

Chicago

Mark Pegram, and Nigel Courtenay-Luck. 2007. “Phase I Study of the Anti-MUC-l Antibody, HuHMFG1 (AS1402), in Patients with Advanced Breast Cancer.” Clinical Immunology 123 (January): S110–11. doi:10.1016/j.clim.2007.03.494.